Naramig
Naramig is a medicine authorised by Swissmedic under authorisation number 54272. The authorisation holder is GlaxoSmithKline AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 30 September 1997 and the authorisation is valid without a time limit. ATC code N02CC02 places the medicine in the group Analgesics.
| Authorisation number | 54272 |
|---|---|
| Name | Naramig |
| Full name | Naramig, Filmtabletten |
| Authorisation holder | GlaxoSmithKline AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | B · Prescription only |
| ATC code | N02CC02 |
| First authorisation | 30 September 1997 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Naramig, Filmtabletten | B | 30 September 1997 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 14 | 6 | Tablette(n) | N02CC02 | 02.05.1. | B |
| 22 | 12 | Tablette(n) | N02CC02 | 02.05.1. | B |
Scroll the table sideways
Other medicines from this authorisation holder
Frequently asked questions
Is Naramig authorised in Switzerland?
Yes. Naramig is authorised by Swissmedic under authorisation number 54272, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Naramig have?
Naramig is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Naramig?
The authorisation holder is GlaxoSmithKline AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.